The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Characterization of the Kynurenine Pathway in Human Neurons
Open accessAbstract
The kynurenine pathway is a major route of l-tryptophan catabolism producing neuroactive metabolites implicated in neurodegeneration and immune tolerance. We characterized the kynurenine pathway in human neurons and the human SK-N-SH neuroblastoma cell line and found that the kynurenine pathway enzymes were variably expressed. Picolinic carboxylase was expressed only in primary and some adult neurons but not in SK-N-SH cells. Because of this difference, SK-N-SH cells were able to produce the excitotoxin quinolinic acid, whereas human neurons produced the neuroprotectant picolinic acid. The net result of kynurenine pathway induction in human neurons is therefore predicted to result in neuroprotection, immune regulation, and tumor inhibition, whereas in SK-N-SH cells, it may result in neurotoxicity, immune tolerance, and tumor promotion. This study represents the first comprehensive characterization of the kynurenine pathway in neurons and the first description of the involvement of the kynurenine pathway as a mechanism for controlling both tumor cell neurotoxicity and persistence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305 · cited 1×
“Uyttenhove et al. (2003) showed that a majority of human tumors constitutively express IDO.”
BackgroundQuinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Tryptophan and the immune response
Moffett, J. R., & Namboodiri, M. A. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01177.x · Cited by 760
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Self-citationGuillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 7×
“Purity of primary cultures of human fetal neurons Consistent with our previous data (Guillemin et al., 2005b), after 7 d in culture, 90 –95% of the fetal brain cells immunostained for the neuronal marker MAP2 (data not shown).”
BackgroundMethodInfluentialSelf-citationHuman macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Foster, A. C., Vezzani, A., French, E. D., & Schwarcz, R. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90050-8 · Cited by 434
Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection
Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A. L., Munn, D. H., & Antonia, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10645 · Cited by 365
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330
Self-citationImmune Suppression in the Tumor Microenvironment
Gajewski, T. F., Meng, Y., & Harlin, H. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000199193.29048.56 · Cited by 265
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid
HEYES, M. P., ACHIM, C. L., WILEY, C. A., MAJOR, E. O., SAITO, K., & MARKEY, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260
Munn, D. H., & Mellor, A. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.11.003 · Cited by 259
Grünblatt, E., Mandel, S., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246
Miller, C. L., Llenos, I. C., Dulay, J. R., & Weis, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.056 · Cited by 242
Miller, C. L., Llenos, I. C., Dulay, J. R., Barillo, M. M., Yolken, R. H., & Weis, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.015 · Cited by 233
Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages
Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, G. J. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_12 · Cited by 229
Self-citationDifferent kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
HEYES, M. P., CHEN, C. Y., MAJOR, E. O., & SAITO, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 214
Stone, T. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01451-6 · Cited by 211
Characteristics of interferon induced tryptophan metabolism in human cells in vitro
Werner-Felmayer, G., Werner, E. R., Fuchs, D., Hausen, A., Reibnegger, G., & Wachter, H. (1989) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(89)90087-6 · Cited by 190
3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum
Guidetti, P., & Schwarcz, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180
Two kynurenine aminotransferases in human brain
Okuno, E., Nakamura, M., & Schwarcz, R. (1991) · Brain Research · doi:10.1016/0006-8993(91)91583-m · Cited by 166
Heyes, M. P., Saito, K., Lackner, A. A., Wiley, C. A., Achim, C. L., & Markey, S. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.881 · Cited by 152
Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α
PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.589 · Cited by 149 · cited 1×
“Interferon- (IFN- ) is known to be the most potent inducer for one of the first enzymes of the kynurenine pathway, indoleamine 2,3-dioxygenase (IDO) (Pemberton et al., 1997).”
BackgroundSelf-citationGuillemin, G. J., Wang, L. H.-C., & Brew, B. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-16 · Cited by 140
Self-citationTumor immune escape mediated by indoleamine 2,3-dioxygenase
Ζαμανάκου, Μ., Germenis, A. E., & Karanikas, V. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.06.001 · Cited by 132
Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus
Du, F., Schmidt, W., Okuno, E., Kido, R., Köhler, C., & Schwarcz, R. M. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903210313 · Cited by 122
Bosco, M. C., Rapisarda, A., Massazza, S., Melillo, G., Young, H. A., & Varesio, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3283 · Cited by 121
Kynurenine metabolism in multiple sclerosis
Hartai, Z., Klivènyi, P., Janáky, T., Penke, B., Dux, L., & Vécsei, L. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00442.x · Cited by 115
Yü, P., Li, Z., Zhang, L., Tagle, D. A., & Cai, T. (2006) · Gene · doi:10.1016/j.gene.2005.09.034 · Cited by 102
Smythe, G. A., Braga, O., Brew, B. J., Grant, R., Guillemin, G. J., Kerr, S. J., & Walker, D. W. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5490 · Cited by 101
Self-citationSaito, K., Chen, C. Y., Masana, M. I., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Biochemical Journal · doi:10.1042/bj2910011 · Cited by 97
In Vivo Uptake and Metabolism of α-[11C]Methyl- l -Tryptophan in Human Brain Tumors
Juhász, C., Chugani, D. C., Muzik, O., Wu, D., Sloan, A. E., Barger, G. R., Watson, C. E., Shah, A. K., Sood, S., Ergün, E. L., et al. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600199 · Cited by 93
Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages
Kerr, S., Armati, P., Pemberton, L., Smythe, G., Tattam, B. N., & Brew, B. (1997) · Neurology · doi:10.1212/wnl.49.6.1671 · Cited by 91
Self-citationObtention and characterization of primary astrocyte and microglial cultures from adult monkey brains
Guillemin, G. J., Boussin, F. D., Croitoru‐Lamoury, J., Franck-Duchenne, M., Grand, R. L., Lazarini, F., & Dormont, D. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970901)49:5<576::aid-jnr8>3.0.co;2-8 · Cited by 83
Self-citationHeyes, M. P., Saito, K., Chen, C. Y., Proescholdt, M. G., Nowak, T. S., Li, J., Beagles, K. E., Proescholdt, M. A., Zito, M. A., Kawai, K., et al. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041519.x · Cited by 82
Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites
Jhamandas, K. H., Boegman, R. J., Beninger, R. J., & Bialik, M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90826-w · Cited by 81
Bresjanac, M., & Antauer, G. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7416 · Cited by 77
Fukuoka, S.-I., Ishiguro, K., Yanagihara, K., Tanabe, A., Egashira, Y., Sanada, H., & Shibata, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200819200 · Cited by 68
Excitotoxicity of quinolinic acid: Modulation by endogenous antagonists
Jhamandas, K. H., Boegman, R. J., Beninger, R. J., Miranda, A., & Lipic, K. A. (2000) · Neurotoxicity Research · doi:10.1007/bf03033790 · Cited by 68
Schroten, H., Spors, B., Hucke, C., Stins, M. F., Kim, K. S., Adam, R., & Däubener, W. (2001) · Neuropediatrics · doi:10.1055/s-2001-17375 · Cited by 64
Fernandez‐Pol, J. A., Klos, D. J., & Hamilton, P. D. (2001) · PubMed · Cited by 51
Tanabe, A., Egashira, Y., Fukuoka, S.-I., Shibata, K., & Sanada, H. (2002) · Journal of Nutrition · doi:10.1093/jn/132.6.1153 · Cited by 43
Kapoor, V., Kapoor, R., & Chalmers, J. P. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02460.x · Cited by 43
Self-citationTesta, U., Louache, F., Titeux, M., THOMOPOULOS, P., & Rochant, H. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07446.x · Cited by 39
Wejksza, K., Rzeski, W., Okuno, E., Kandefer‐Szerszeń, M., Albrecht, J., & Turski, W. A. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6178-z · Cited by 39
The Kynurenine Pathway and Neurologic Disease
Heyes, M. P. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_20 · Cited by 37
Mass spectrometric detection of quinolinic acid in microdissected Alzheimer's disease plaques
Guillemin, G. J., Brew, B. J., Noonan, C. E., Knight, T. G., Smythe, G. A., & Cullen, K. M. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.012 · Cited by 36
Self-citationRzeski, W., Kocki, T., Dybel, A., Wejksza, K., Zdzisińska, B., Kandefer‐Szerszeń, M., Turski, W. A., Okuno, E., & Albrecht, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20505 · Cited by 35
Selective toxicity induced by picolinic acid in simian virus 40-transformed cells in tissue culture.
Fernandez‐Pol, J. A., & Johnson, G. S. (1977) · PubMed · Cited by 32
Antitumor Activity of Picolinic Acid in CBA/J Mice 2 3
Leuthauser, S. W. C., Oberley, L. W., & Oberley, T. D. (1982) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/68.1.123 · Cited by 32
Blasi, E., Barluzzi, R., Mazzolla, R., & Bistoni, F. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3476-3481.1993 · Cited by 31
Picolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro
Vrooman, L. M., Jhamandas, K. H., Boegman, R. J., & Beninger, R. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90320-m · Cited by 31
Neuronal localization of indoleamine 2,3-dioxygenase in mice
Roy, E. J., Takikawa, O., Kranz, D. M., Brown, A. R., & Thomas, D. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.010 · Cited by 29
Self-citationImmunobiology of Picolinic Acid
Melillo, G., Bosco, M. C., Musso, T., & Varesio, L. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_22 · Cited by 26
Hansford, L. M., & Marshall, G. M. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.034 · Cited by 21
Brain tryptophan. Normal and disturbed control.
Curzon, G. (1996) · PubMed · Cited by 19
Curzon, G. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_3 · Cited by 11
Platten, M., Ho, P. P.-K., & Steinman, L. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.09.005 · Cited by 10
Curzon, G. (1996) · Cited by 6
Research works printed but not linked: 4
- Curatolo, 1996, Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes, Adv Exp Med Biol, 398, 273, 10.1007/978-1-4613-0381-7_43 · doi:10.1007/978-1-4613-0381-7_43
- Kerr, 1997, Kynurenine pathway inhibition with 6-chloro-D-tryptophan reduces neurotoxicity of HIV-infected macrophage supernatants (Abstract), Neurology, 48, A94
- Kovalenko, 1989, [The effect of picolinic acid and iron ions on the proliferation of SPEV cells.], Tsitologiia, 31, 447
- 10.1007/s10571-005-8469-y · DOI
Cited by
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641
Kynurenine Pathway Metabolites in Humans: Disease and Healthy States
Chen, Y., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 628
Self-citation
Metadata
- Authors
- Guillemin, G. J., Cullen, K. M., Lim, C. K., Smythe, G. A., Garner, B., Kapoor, V., Takikawa, O., & Brew, B. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-11-21
- Volume
- 27
- Issue
- 47
- Pages
- 12884-12892
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2053806684
- Cited by
- 324
- References
- 64
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.